All charts and data below are with dividends reinvested. (Inflation adjustment is OFF !)
| Fri 2018-12-07? to Fri 2024-12-20 |
YTD
Return |
TR
Price |
||||
|---|---|---|---|---|---|---|
| MRNA × |
−60.39%
2024-12-20 |
2.118 TR
2024-12-20 |
||||
| Moderna Inc NASDAQ Common Stock | ||||||
| Fri 2018-12-07? to Fri 2024-12-20 |
Overall
Return |
Exponential
Trendline |
||||
|---|---|---|---|---|---|---|
| MRNA × |
+111.77%
+13.23%/yr |
+33.88%/yr
(R2=0.309) |
||||
| Moderna Inc NASDAQ Common Stock | ||||||
| Fri 2018-12-07? to Fri 2024-12-20 |
Start
Value |
End
Value |
||||
|---|---|---|---|---|---|---|
| MRNA × |
$10,000.00
2018-12-07 |
$21,177.42
2024-12-20 |
||||
| Moderna Inc NASDAQ Common Stock | ||||||
| Year | MRNA |
|---|---|
| 2024 (YTD) | −60.39% |
| 2023 | −44.63% |
| 2022 | −29.28% |
| 2021 | +143.11% |
| 2020 | +434.10% |
| 2019 | +28.09% |
| 2018 | −17.90% |
| Fri 2018-12-07? to Fri 2024-12-20 |
Current
Drawdown |
Worst
Drawdown |
||||
|---|---|---|---|---|---|---|
| MRNA × | −91.87% |
−92.39%
2024-11-15 |
||||
| Moderna Inc NASDAQ Common Stock | ||||||